Search - tctmd.com

Displaying 1 - 20 of 270

Sort: Relevancy | Date

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

Podcast Heart Valve Matters

Tricuspid Series: Heart Failure Management

November 06, 2025

Presentation TCT 2025

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

Presenter: Yan Wang

October 27, 2025

Presentation TCT 2025

TCT 36: Mid-term Outcomes of Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Replacement

Presenter: Konstantinos Stathogiannis

October 27, 2025

Presentation TCT 2025

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

Presenter: Himanshi Banker

October 27, 2025

Presentation TCT 2025

TCT 865: Impact of a Standardized Algorithm on Device Selection in Severe Tricuspid Regurgitation

Presenter: Omar Sami Abdelhai

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

Presentation TCT 2025

TCT 989: A physics-based computational simulation model to study transcatheter tricuspid valve replacements in patients with severe tricuspid regurgitation

Presenter: Luis Rene Mata Quinonez

October 26, 2025

Presentation TCT 2025

TCT 991: Hemodynamic and Echocardiographic Effects of TTVR in Patients with Severe Tricuspid Regurgitation

Presenter: Tobias Geisler

October 26, 2025

Presentation TCT 2025

TCT 984: Comparison of Invasive and Non-Invasive Assessment of Right Ventricular Function Using Pressure-Volume Loops in Patients with Severe Tricuspid Regurgitation Undergoing Percutaneous Tricuspid Valve Replacement

Presenter: Vivek Mehta

October 26, 2025

Presentation TCT 2025

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

Presenter: Santiago Garcia

October 26, 2025

Presentation TCT 2025

A Novel Strategy Targeting Caval Reflux to Alleviate Right Heart Failure in Severe Tricuspid Regurgitation: Early Results of the TRICAV EFS of TRIcvalve (Products+Features)

Presenter: Rishi Puri

October 26, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

Todd Neale

October 22, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

Yael L. Maxwell

September 04, 2025

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

News Daily News

Balloon, Self-Expanding TAVI Devices Provide Similar Results in Bicuspid Valves

Caitlin E. Cox

August 26, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

Advertisement

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Tricuspid Series: Heart Failure Management

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

TCT 36: Mid-term Outcomes of Patients With Severe Tricuspid Regurgitation Undergoing Transcatheter Tricuspid Valve Replacement

TCT 864: Comparative Outcomes of Tricuspid transcatheter edge-to-edge repair (T-TEER) Versus Medical Therapy (MT) in Severe Tricuspid Regurgitation (TR): A Systematic Review and Meta-analysis

TCT 865: Impact of a Standardized Algorithm on Device Selection in Severe Tricuspid Regurgitation

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

TCT 989: A physics-based computational simulation model to study transcatheter tricuspid valve replacements in patients with severe tricuspid regurgitation

TCT 991: Hemodynamic and Echocardiographic Effects of TTVR in Patients with Severe Tricuspid Regurgitation

TCT 984: Comparison of Invasive and Non-Invasive Assessment of Right Ventricular Function Using Pressure-Volume Loops in Patients with Severe Tricuspid Regurgitation Undergoing Percutaneous Tricuspid Valve Replacement

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

A Novel Strategy Targeting Caval Reflux to Alleviate Right Heart Failure in Severe Tricuspid Regurgitation: Early Results of the TRICAV EFS of TRIcvalve (Products+Features)

TTVR Remains Safe, Effective in Presence of CIED Leads

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

What’s Going to Be Hot at TCT 2025

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

ESC/EACTS Release New Valvular Heart Disease Guidelines

Balloon, Self-Expanding TAVI Devices Provide Similar Results in Bicuspid Valves

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content